Skip to main content
. 2020 Jan 30;11:100255. doi: 10.1016/j.abrep.2020.100255

Table 1.

Summary of smoking cessation clinical trial studies in inpatient psychiatry and substance use treatment facilities.

Author (year published) Outcome Measures Setting Population Mean Age Mean cigarettes per day Treatment Type Follow-up (months) Sample size
Metse et al. (2017) 1-Month prolonged abstinence
7-day point prevalence abstinence
Started in inpatient psychiatric facilities and continued post-discharge Inpatients at 4 psychiatric facilities in Australia 38.7 Usual care compared to brief MI plus 4-month pharmacological & psychosocial intervention post discharge 4, 6–12 754
Schuck et al. (2016) Number of 24 h quit attempts Started in Inpatient psychiatry Adult inpatients from seven from seven psychiatric units at 3 San Francisco Bay Area hospitals. 39 17 Usual care compared to brief (3 months) treatment group, and extended (6 months) treatment group.
Treatment groups received transtheoretical-model tailored computer intervention. NRT was given to participants
18 956
Smith et al. (2016) Reduce smoking and improvement of cognition A meaningful portion of the sample were inpatients Patients with schizophrenia 45.1 17.6 Varenicline compared to placebo 8-weeks treatment 87
Hickman III et al. (2015) 7-day point prevalence abstinence From three psychiatric units at San Francisco General Hospital. 10-week post hospital NRT Adult smokers uninsured, indigent, unhoused 39.5 19 NRT + Advice compared to Transtheoretical – model tailored computer-assisted intervention 100
Stockings et al. (2014) 7-day point prevalence abstinence Initiated in inpatient care and continued for 4-months post-discharge Patient smokers at an inpatient psychiatric facility in Australia 37.6 23.0 Usual Treatment compared to psychosocial and pharmacological (NRT) support 205
Prochaska et al. (2014) Verified 7-day point prevalence abstinence Initiated in Inpatient Psychiatry and continued in outpatient treatment
10-week post NRT?
Patients in locked acute psychiatry unit at the Langley Porter Psychiatric Institute at the University of California 19.0 Usual care compared to (Motivational interviewing + NRT) 18-months
NRT was provided for 10 weeks
224
Chen et al. (2013) Smoking reduction, and 7-day point prevalence abstinence Inpatients with schizophrenia and schizoaffective disorders Two public inpatient psychiatry facilities in Taiwan 45.2 13.1 High dose NRT (31.2 mg) compared to Low dose NRT (20.8 mg) 8-weeks treatment 184
Brown et al. (2003) Point prevalence abstinence, quit attempts, change in smoking rate, and longest quit attempt Psychiatry inpatient Adolescents at a private university hospital in Providence Rhode Island 13–17 Motivational Interviewing (MI) versus brief advice (BA). MI was two 45 min sessions and BA was 5–10 min advice with quit information. NRT was provided at discharge 1, 3, 6, 9, and 12 191